Bio-Gate AG Stock
Bio-Gate AG Stock
Bio-Gate AG gained 2.800% today.
Our community identified positive and negative aspects for Bio-Gate AG stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bio-Gate AG stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of Bio-Gate AG in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Gate AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Gate AG | 2.800% | -8.333% | -5.983% | -44.162% | -31.250% | -60.993% | -88.397% |
| Alpha Pro Tech Ltd. | - | -2.315% | -13.878% | 0.957% | 14.674% | 19.209% | -52.316% |
| Eifelhoehen-Klinik | - | 8.421% | 5.641% | 180.272% | 64.800% | 96.190% | 19.075% |
| Maternus-Kliniken AG | -0.550% | 1.111% | 1.676% | -27.778% | -2.151% | -59.735% | -79.688% |
News
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
